Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaili Ren

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Future Oncology (London, England)|October 9, 2023
<i>In</i>-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myelomaRobert M Rifkin, Caitlin L Costello, Ruemu E Birhiray, et al.
Scientific Reports|August 13, 2017
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney DiseaseJeffrey X Xie, Helen Alderson, James Ritchie, et al.
Plos One|March 18, 2017
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosisChristopher A Drummond, Pamela S Brewster, Wencan He, et al.
European Journal of Haematology|January 13, 2026
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data AnalysisNoemi Puig, Xavier Leleu, Hans C Lee, et al.
Journal of the American Heart Association|August 22, 2019
Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery StenosisEmily L Cooper, Yanmei Xie, Hanh Nguyen, et al.
BMJ Open|August 7, 2021
Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort studyJulia Zhu, Zhongyuan Wei, Manasi Suryavanshi, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2023
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma PatientsMichael A Thompson, Mario Boccadoro, Xavier Leleu, et al.
BMJ Open|March 1, 2022
Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort studyJohn H Page, Ajit A Londhe, Corinne Brooks, et al.
Future Oncology (London, England)|March 26, 2021
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myelomaRoman Hájek, Jiří Minařík, Jan Straub, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Future Oncology (London, England)|October 9, 2023
<i>In</i>-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myelomaRobert M Rifkin, Caitlin L Costello, Ruemu E Birhiray, et al.
Scientific Reports|August 13, 2017
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney DiseaseJeffrey X Xie, Helen Alderson, James Ritchie, et al.
Plos One|March 18, 2017
Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosisChristopher A Drummond, Pamela S Brewster, Wencan He, et al.
European Journal of Haematology|January 13, 2026
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data AnalysisNoemi Puig, Xavier Leleu, Hans C Lee, et al.
Journal of the American Heart Association|August 22, 2019
Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery StenosisEmily L Cooper, Yanmei Xie, Hanh Nguyen, et al.
BMJ Open|August 7, 2021
Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort studyJulia Zhu, Zhongyuan Wei, Manasi Suryavanshi, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 14, 2023
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma PatientsMichael A Thompson, Mario Boccadoro, Xavier Leleu, et al.
BMJ Open|March 1, 2022
Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort studyJohn H Page, Ajit A Londhe, Corinne Brooks, et al.
Future Oncology (London, England)|March 26, 2021
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myelomaRoman Hájek, Jiří Minařík, Jan Straub, et al.
Pageof 5